Eskazole is a medicine containing the active ingredient(s) albendazole. On this page you will find out more about Eskazole, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: albendazole
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Eskazole 400 mg tablet, 56
Consumer Medicine Information leaflet:
No consumer medicine information leaflet was found for the pack size you selected. It may be unavailable or there may be a technical problem. You should speak to your pharmacist, healthcare professional, or call healthdirect on 1800 022 222 for more information.
What this medicine is for
HYDATID DISEASE: Albendazole is indicated for the treatment of hydatid cysts caused by E. granulosus in adults and children over 6 years of age, where surgical intervention is not feasible because of anatomic site or the presence of multiple cysts. Albendazole shows greatest efficacy in the treatment of liver, lung and peritoneal cysts. Experience with bone cysts or those in the heart or central nervous system is limited, but cases of successful treatment with prolonged course of albendazole have been reported. Albendazole may also be used as an adjunct to surgical excision of hydatid cysts either: 1) prior to surgical intervention, or 2) post-operatively, if pre-operative treatment was too short (less than two separate 28-day cycles) or if viable cysts are found at surgery. LARVAL TAENIASIS (NEUROCYSTICERCOSIS): Albendazole is effective in the treatment of neurocysticercosis (NCC) in courses as short as 7 days. OTHER INDICATIONS: There is also evidence that albendazole is effective against Capillaria philippinensis in courses of 10 days.
Table of characteristics
|Visual appearance||Mottled pale orange rounded oblong biconvex tablets with a score line on one side, and embossed "ALB 400" on the reverse, and a characteristic fruity odour.|
|Dosage Form||Tablet, chewable|
|Route of administration||Oral|
56 tablets: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 30 degrees Celsius|
|Storage conditions||No information available|
|Life time||5 Years|
We were unable to verify that this medicine is available on the PBS (Pharmaceutical Benefits Scheme). Please consult your pharmacist if you need further information
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.